Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Wu, Jing Qin ^a,b,c   Wang, Xi ^b,c   Beveridge, Natalie J ^a,b,c   Tooney, Paul A ^a,b,c   Scott, Rodney J ^b,c   Carr, Vaughan J ^a,d   Cairns, Murray J ^a,b,c  

^a SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLECORTIN LIKE KINASE 1; NEUROLEPTIC AGENT; PHOSPHOTRANSFERASE; TRANSCRIPTOME; UNCLASSIFIED DRUG; DCLK1 PROTEIN, HUMAN; MESSENGER RNA; PROTEIN SERINE THREONINE KINASE; RNA ISOFORM; SIGNAL PEPTIDE;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MALE; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; PROMOTER REGION; RNA SEQUENCE; RNA SPLICING; SCHIZOPHRENIA; SEQUENCE ALIGNMENT; SUPERIOR TEMPORAL GYRUS; SYNAPSE VESICLE; ADOLESCENT; ALTERNATIVE RNA SPLICING; CASE CONTROL STUDY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; REPRODUCIBILITY; SEQUENCE ANALYSIS; SYNAPSE;

ADOLESCENT; ADULT; AGED; ALTERNATIVE SPLICING; BASE SEQUENCE; CASE-CONTROL STUDIES; CEREBRAL CORTEX; GENE EXPRESSION PROFILING; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; REPRODUCIBILITY OF RESULTS; RNA ISOFORMS; RNA, MESSENGER; SCHIZOPHRENIA; SEQUENCE ANALYSIS, RNA; SYNAPSES; YOUNG ADULT;

EID: 84860430130     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036351     Document Type: Article

References (82)

1. Carpenter WT Jr, Buchanan RW, (1994) Schizophrenia. N Engl J Med 330: 681-690.
2. Lewis DA, Levitt P, (2002) Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 25: 409-432.
3. Marenco S, Weinberger DR, (2000) The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev Psychopathol 12: 501-527.
4. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, et al. (2001) Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A 98: 4746-4751.
5. Iwamoto K, Bundo M, Kato T, (2005) Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 14: 241-253.
6. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P, (2002) Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 22: 2718-2729.
7. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P, (2000) Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28: 53-67.
8. Mirnics K, Middleton FA, Lewis DA, Levitt P, (2001) Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci 24: 479-486.
9. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, et al. (2003) Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362: 798-805.
10. Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P, (2001) Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 6: 293-301.
11. Vawter MP, Crook JM, Hyde TM, Kleinman JE, Weinberger DR, et al. (2002) Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res 58: 11-20.
12. Katsel P, Davis KL, Gorman JM, Haroutunian V, (2005) Variations in differential gene expression patterns across multiple brain regions in schizophrenia. Schizophr Res 77: 241-252.
13. Mimmack ML, Ryan M, Baba H, Navarro-Ruiz J, Iritani S, et al. (2002) Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc Natl Acad Sci U S A 99: 4680-4685.
14. Vawter MP, Barrett T, Cheadle C, Sokolov BP, Wood WH 3rd, et al. (2001) Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull 55: 641-650.
15. Weidenhofer J, Bowden NA, Scott RJ, Tooney PA, (2006) Altered gene expression in the amygdala in schizophrenia: up-regulation of genes located in the cytomatrix active zone. Mol Cell Neurosci 31: 243-250.
16. Chung C, Tallerico T, Seeman P, (2003) Schizophrenia hippocampus has elevated expression of chondrex glycoprotein gene. Synapse 50: 29-34.
17. Altar CA, Jurata LW, Charles V, Lemire A, Liu P, et al. (2005) Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 58: 85-96.
18. McCullumsmith RE, Gupta D, Beneyto M, Kreger E, Haroutunian V, et al. (2007) Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia. Schizophr Res 90: 15-27.
19. Aston C, Jiang L, Sokolov BP, (2004) Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res 77: 858-866.
20. Rajarethinam RP, DeQuardo JR, Nalepa R, Tandon R, (2000) Superior temporal gyrus in schizophrenia: a volumetric magnetic resonance imaging study. Schizophr Res 41: 303-312.
21. Honea R, Crow TJ, Passingham D, Mackay CE, (2005) Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 162: 2233-2245.
22. Bowden NA, Scott RJ, Tooney PA, (2008) Altered gene expression in the superior temporal gyrus in schizophrenia. BMC Genomics 9: 199.
23. Aston C, Jiang L, Sokolov BP, (2005) Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 10: 309-322.
24. Horesh Y, Katsel P, Haroutunian V, Domany E, (2011) Gene expression signature is shared by patients with Alzheimer's disease and schizophrenia at the superior temporal gyrus. Eur J Neurol 18: 410-424.
25. Morozova O, Marra MA, (2008) Applications of next-generation sequencing technologies in functional genomics. Genomics 92: 255-264.
26. Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y, (2008) RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res 18: 1509-1517.
27. Sultan M, Schulz MH, Richard H, Magen A, Klingenhoff A, et al. (2008) A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 321: 956-960.
28. Richard H, Schulz MH, Sultan M, Nurnberger A, Schrinner S, et al. (2010) Prediction of alternative isoforms from exon expression levels in RNA-Seq experiments. Nucleic Acids Res 38: e112.
29. Honer WG, Falkai P, Bayer TA, Xie J, Hu L, et al. (2002) Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. Cereb Cortex 12: 349-356.
30. Young CE, Arima K, Xie J, Hu L, Beach TG, et al. (1998) SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cereb Cortex 8: 261-268.
31. Gabriel SM, Haroutunian V, Powchik P, Honer WG, Davidson M, et al. (1997) Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia. Arch Gen Psychiatry 54: 559-566.
32. Mukaetova-Ladinska EB, Hurt J, Honer WG, Harrington CR, Wischik CM, (2002) Loss of synaptic but not cytoskeletal proteins in the cerebellum of chronic schizophrenics. Neurosci Lett 317: 161-165.
33. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, et al. (2008) Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 40: 827-834.
34. Altar CA, Vawter MP, Ginsberg SD, (2009) Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology 34: 18-54.
35. Sequeira PA, Martin MV, Vawter MP, (2012) The first decade and beyond of transcriptional profiling in schizophrenia. Neurobiol Dis 45: 23-36.
36. Haroutunian V, Katsel P, Dracheva S, Stewart DG, Davis KL, (2007) Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia. Int J Neuropsychopharmacol 10: 565-573.
37. Merico D, Isserlin R, Stueker O, Emili A, Bader GD, (2010) Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One 5: e13984.
38. Deng X, Takaki H, Wang L, Kuroki T, Nakahara T, et al. (2011) Positive association of phencyclidine-responsive genes, PDE4A and PLAT, with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 156B: 850-858.
39. Sollner T, Whiteheart SW, Brunner M, Erdjument-Bromage H, Geromanos S, et al. (1993) SNAP receptors implicated in vesicle targeting and fusion. Nature 362: 318-324.
40. Seiler F, Malsam J, Krause JM, Sollner TH, (2009) A role of complexin-lipid interactions in membrane fusion. FEBS Lett 583: 2343-2348.
41. Martens S, Kozlov MM, McMahon HT, (2007) How synaptotagmin promotes membrane fusion. Science 316: 1205-1208.
42. Ferreira A, Rapoport M, Ferreira A, Chin LS, Li L, et al. (2002) The synapsins: beyond the regulation of neurotransmitter release. Cell Mol Life Sci 59: 589-595.
43. Edelmann L, Hanson PI, Chapman ER, Jahn R, (1995) Synaptobrevin binding to synaptophysin: a potential mechanism for controlling the exocytotic fusion machine. Embo J 14: 224-231.
44. Uriu Y, Kiyonaka S, Miki T, Yagi M, Akiyama S, et al. (2010) Rab3-interacting molecule gamma isoforms lacking the Rab3-binding domain induce long lasting currents but block neurotransmitter vesicle anchoring in voltage-dependent P/Q-type Ca2+ channels. J Biol Chem 285: 21750-21767.
45. Block MR, Glick BS, Wilcox CA, Wieland FT, Rothman JE, (1988) Purification of an N-ethylmaleimide-sensitive protein catalyzing vesicular transport. Proc Natl Acad Sci U S A 85: 7852-7856.
46. Barakauskas VE, Beasley CL, Barr AM, Ypsilanti AR, Li HY, et al. (2010) A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia. Neuropsychopharmacology 35: 1226-1238.
47. Chana G, Lucero G, Salaria S, Lozach J, Du P, et al. (2009) Upregulation of NRG-1 and VAMP-1 in human brain aggregates exposed to clozapine. Schizophr Res 113: 273-276.
48. Sommer JU, Schmitt A, Heck M, Schaeffer EL, Fendt M, et al. (2010) Differential expression of presynaptic genes in a rat model of postnatal hypoxia: relevance to schizophrenia. Eur Arch Psychiatry Clin Neurosci 260 (Suppl 2): S81-89.
49. Kontkanen O, Toronen P, Lakso M, Wong G, Castren E, (2002) Antipsychotic drug treatment induces differential gene expression in the rat cortex. J Neurochem 83: 1043-1053.
50. Karson CN, Mrak RE, Schluterman KO, Sturner WQ, Sheng JG, et al. (1999) Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'. Mol Psychiatry 4: 39-45.
51. Mudge J, Miller NA, Khrebtukova I, Lindquist IE, May GD, et al. (2008) Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum. PLoS One 3: e3625.
52. Mirnics K, Levitt P, Lewis DA, (2006) Critical appraisal of DNA microarrays in psychiatric genomics. Biol Psychiatry 60: 163-176.
53. Duncan CE, Chetcuti AF, Schofield PR, (2008) Coregulation of genes in the mouse brain following treatment with clozapine, haloperidol, or olanzapine implicates altered potassium channel subunit expression in the mechanism of antipsychotic drug action. Psychiatr Genet 18: 226-239.
54. Zink M, Schmitt A, May B, Muller B, Demirakca T, et al. (2004) Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression. Schizophr Res 66: 151-157.
55. Schachner M, Bartsch U, (2000) Multiple functions of the myelin-associated glycoprotein MAG (siglec-4a) in formation and maintenance of myelin. Glia 29: 154-165.
56. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, et al. (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9: 684-697, 643.
57. MacDonald ML, Naydenov A, Chu M, Matzilevich D, Konradi C, (2006) Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. Bipolar Disord 8: 255-264.
58. Voos W, Rottgers K, (2002) Molecular chaperones as essential mediators of mitochondrial biogenesis. Biochim Biophys Acta 1592: 51-62.
59. Aitken A, Baxter H, Dubois T, Clokie S, Mackie S, et al. (2002) Specificity of 14-3-3 isoform dimer interactions and phosphorylation. Biochem Soc Trans 30: 351-360.
60. Schwab SG, Hallmayer J, Albus M, Lerer B, Eckstein GN, et al. (2000) A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Mol Psychiatry 5: 638-649.
61. Koizumi H, (2007) Physiological function of the DCX family in brain development. Seikagaku 79: 1134-1139.
62. Burgess HA, Reiner O, (2000) Doublecortin-like kinase is associated with microtubules in neuronal growth cones. Mol Cell Neurosci 16: 529-541.
63. Silverman MA, Benard O, Jaaro H, Rattner A, Citri Y, et al. (1999) CPG16, a novel protein serine/threonine kinase downstream of cAMP-dependent protein kinase. J Biol Chem 274: 2631-2636.
64. Burgess HA, Martinez S, Reiner O, (1999) KIAA0369, doublecortin-like kinase, is expressed during brain development. J Neurosci Res 58: 567-575.
65. Verissimo CS, Molenaar JJ, Meerman J, Puigvert JC, Lamers F, et al. (2010) Silencing of the microtubule-associated proteins doublecortin-like and doublecortin-like kinase-long induces apoptosis in neuroblastoma cells. Endocr Relat Cancer 17: 399-414.
66. Sokolov BP, (2007) Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies? Int J Neuropsychopharmacol 10: 547-555.
67. Nave KA, Lai C, Bloom FE, Milner RJ, (1987) Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proc Natl Acad Sci U S A 84: 5665-5669.
68. Sporkel O, Uschkureit T, Bussow H, Stoffel W, (2002) Oligodendrocytes expressing exclusively the DM20 isoform of the proteolipid protein gene: myelination and development. Glia 37: 19-30.
69. Jacobs EC, Bongarzone ER, Campagnoni CW, Campagnoni AT, (2004) Embryonic expression of the soma-restricted products of the myelin proteolipid gene in motor neurons and muscle. Neurochem Res 29: 997-1002.
70. Jahn O, Tenzer S, Werner HB, (2009) Myelin proteomics: molecular anatomy of an insulating sheath. Mol Neurobiol 40: 55-72.
71. Gow A, Gragerov A, Gard A, Colman DR, Lazzarini RA, (1997) Conservation of topology, but not conformation, of the proteolipid proteins of the myelin sheath. J Neurosci 17: 181-189.
72. Faludi G, Mirnics K, (2011) Synaptic changes in the brain of subjects with schizophrenia. Int J Dev Neurosci 2011: 4.
73. Beveridge NJ, Gardiner E, Carroll AP, Tooney PA, Cairns MJ, (2010) Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatry 15: 1176-1189.
74. Beveridge NJ, Tooney PA, Carroll AP, Gardiner E, Bowden N, et al. (2008) Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet 17: 1156-1168.
75. Trapnell C, Pachter L, Salzberg SL, (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105-1111.
76. Langmead B, Trapnell C, Pop M, Salzberg SL, (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
77. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B, (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621-628.
78. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, et al. (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28: 511-515.
79. Pruitt KD, Tatusova T, Klimke W, Maglott DR, (2009) NCBI Reference Sequences: current status, policy and new initiatives. Nucleic Acids Res 37: D32-36.
80. Santarelli DM, Beveridge NJ, Tooney PA, Cairns MJ, (2011) Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol Psychiatry 69: 180-187.
81. Young MD, Wakefield MJ, Smyth GK, Oshlack A, (2010) Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol 11: R14.
82. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, et al. (2007) Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2: 2366-2382.